WARF: P01325US

  • Assigned to WARF as biological material.

A Transgenic Mouse Model for Human Liver Disease


Eric Sandgren, Kristin Braun, Teresa Weglarz, Jay Degen

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in a transgenic mouse model for human liver disease.
OVERVIEWMany of those currently on waiting lists for liver transplants are victims of liver failure associated with hepatocyte toxicity. This toxicity can be caused by alcohol abuse, or by prescription or non-prescription drugs. For example, such liver disease caused by excessive doses of acetaminophen has recently been noted in the press.
THE INVENTIONUW–Madison researchers have developed an excellent transgenic mouse model for human liver disease. They used a genetic construct comprising the albumin gene regulatory element linked to the herpes simplex thymidine kinase gene to create the mouse. When an inducing agent, such as the drug gancyclovir, is administered to the mouse, it develops liver disease.
  • Provides a means of testing therapies to prolong survival in humans with liver disease
  • Liver disease in the mouse closely mimics human liver disease
  • Superior to existing mouse models of liver disease
For More Information About the Inventors
Contact Information
For current licensing status, please contact Jennifer Gottwald at or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.